Clinical trial · Interventional
Horse Therapy for Children, Adolescents and Young Adults in Remission From Medulloblastoma
Pilot Study Evaluating Feasibility and Acceptability of Horse Therapy for Children, Adolescents and Young Adults in Remission From Medulloblastoma and Describing the Evolution of Their Physical and Psychological Characteristics
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
On average, each year in the former region, 60 new patients under the age of 18 are treated for a brain tumor, with an active post-treatment follow-up file of 350 patients. Because of the significant sequelae induced by the disease or the treatments, these patients will very often require rehabilitative care. The interest of involving the horse in the population of patients cured of a medulloblastoma but with important physical and psychological after-effects is to be able to combine a therapy using animal mediation (equitherapy) and a rehabilitation therapy based on the three-dimensional movement of the horse (hippotherapy).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neuroblastoma | Neuroblastoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| horse therapy | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- horse therapy
- interventionNames
- Other: horse therapy
Primary outcomes (1)
- measure
- number of sessions performed
- timeFrame
- 16 weeks
- description
- number of sessions equitherapy and hippotherapy performed
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 10 Years
- Maximum age
- 26 Years
Show eligibility criteria text
Inclusion Criteria: * complete remission of medulloblastoma and after 5 years of the end of treatment * living within 30 km away the riding center and/or less than 1 hour of transport * informed consent Exclusion Criteria: * Landsky score below 50% for minors until 16 years old and Karnofsky score below 50% for patients over 16 years * major under juridical protection
References
Publications (0)
Data not yet available